- Home
- MLI vs EXEL Comparison
MLI vs EXEL Comparison
Compare MLI & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLI
- EXEL
- Stock Information
- Founded
- MLI 1917
- EXEL 1994
- Country
- MLI United States
- EXEL United States
- Employees
- MLI N/A
- EXEL N/A
- Industry
- MLI Metal Fabrications
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLI Industrials
- EXEL Health Care
- Exchange
- MLI Nasdaq
- EXEL Nasdaq
- Market Cap
- MLI 10.3B
- EXEL 9.7B
- IPO Year
- MLI N/A
- EXEL 2000
- Fundamental
- Price
- MLI $78.36
- EXEL $35.37
- Analyst Decision
- MLI Hold
- EXEL Buy
- Analyst Count
- MLI 1
- EXEL 18
- Target Price
- MLI N/A
- EXEL $31.72
- AVG Volume (30 Days)
- MLI 2.0M
- EXEL 2.0M
- Earning Date
- MLI 10-22-2024
- EXEL 10-29-2024
- Dividend Yield
- MLI 0.98%
- EXEL N/A
- EPS Growth
- MLI N/A
- EXEL 441.02
- EPS
- MLI 5.14
- EXEL 1.55
- Revenue
- MLI $3,577,607,000.00
- EXEL $2,081,598,000.00
- Revenue This Year
- MLI $10.37
- EXEL $20.59
- Revenue Next Year
- MLI $10.09
- EXEL $1.50
- P/E Ratio
- MLI $15.71
- EXEL $22.99
- Revenue Growth
- MLI 0.34
- EXEL 17.31
- 52 Week Low
- MLI $41.94
- EXEL $19.20
- 52 Week High
- MLI $96.81
- EXEL $36.97
- Technical
- Relative Strength Index (RSI)
- MLI 41.14
- EXEL 60.60
- Support Level
- MLI $80.34
- EXEL $35.57
- Resistance Level
- MLI $82.49
- EXEL $36.97
- Average True Range (ATR)
- MLI 2.60
- EXEL 0.81
- MACD
- MLI -1.70
- EXEL -0.25
- Stochastic Oscillator
- MLI 5.37
- EXEL 48.41
About MLI Mueller Industries Inc.
Mueller Industries Inc makes copper, brass, aluminum, and plastic products. The company reports three business segments: piping systems, industrial metals, and climate. Piping systems, earning majority of the company's revenue, produces tubes, fittings, rods, valves, and other products and operates various firms world-wide. The industrial metals segment manufactures impacts and micro-gauge, brass rod and copper bar products, and brass value-added products. The climate segment produces items used to create temperature-control goods, including valves, twisted tubes, coaxial heat exchangers, and others. Numerous systems use the aforementioned products, including HVAC, water distribution, refrigeration, and automotive.
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.